Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Merck To Work With AmoyDx On Colorectal Cancer Liquid Biopsy Assay

Executive Summary

Germany-based Merck will work to develop the test based on AmoyDx's real-time polymerase chain reaction technology, with goals to launch in China in 2017.


Related Content

China Dips Its Toes in Disruptive IVD Tech


Related Companies